Saints Capital is a merchant venture capital firm with offices located in San Francisco and London.  They are a direct secondary acquirer of venture capital and private equity investments in emerging growth companies.  Saints Capital also makes traditional direct venture capital investments on a primary basis and in special situations in technology, health care, consumer and industrial companies in the Unites States.

Saints Capital

BASF Venture Capital is the corporate venture capital arm of BASF Group. They invest worldwide in promising young enterprises relevant to BASF’s current and future business fields and also in funds. Besides innovations in the fields of chemistry, new materials and sustainability, their areas of focus include digitization and new business models. They support their portfolio companies through selective interactions with the global research, partnership and customer networks of the BASF Group. They are headquartered in Ludwigshafen, Germany and have offices in San Francisco, Boston, Shanghai, Sao Paulo, and Tel Aviv.

BASF Venture Capital

CMEA Ventures is a San Francisco based venture capital firm that specializes in high technology, life sciences, and alternative energy investments. The firm invests in both early and late stage companies, and actively partners with its extended network of companies, other VC firms, institutional investors, strategic partners as well as entrepreneurs. CMEA was originally formed as an affiliate of New Enterprise Associates (NEA) in 1989 and became independent in 1997. CMEA currently has 74 portfolio companies, 6 funds and manages $1.2 billion of venture capital.

CMEA Ventures

Mandala focuses exclusively on long-term investment in the food industries of the Indian sub-continent.  Mandala partners with companies which have potential to become clear leaders in their sector.  Mandala offers capital and expertise to realise plans which strongly enhance the value of our partners’ companies.

Mandala Capital

CMEA closed in April of 2015 and has unveiled its new corporate identity as [Presidio Partners](https://www.crunchbase.com/organization/presidio-partners).  CMEA Capital is a venture capital firm with a clear focus on life sciences, high technology, and energy and materials investments. We believe that the most successful venture backed companies are those that are science based, with experienced teams that have a vision. As a result, CMEA typically invests in companies that have cutting edge and highly differentiated technology at their core and founding teams of the highest caliber still in place. These are companies that have the potential to transform their industries.  CMEA Capital was founded in 1989 and maintains offices in San Francisco and Menlo Park. We invest in both early and late stage science-focused ventures, and leverage a strong network of corporate, investment, and entrepreneurial relationships on behalf of portfolio companies. Our partners and associates have extensive science, engineering, and operational backgrounds, providing us the confidence to look beyond today's technology. We apply our focus on science and teams to our collaborations with entrepreneurs and venture investment partners who are changing the world, one great company at a time.

CMEA Capital

Arcadia Biosciences

Arcadia Biosciences is an agricultural technology company focused on developing products that benefit the environment and human health. The company uses advanced screening, breeding and biotechnology techniques (both GM and non-GM) to create value for consumers, processors and farmers.  Arcadia’s agronomic performance traits, which include nitrogen use efficiency, water use efficiency, salt tolerance, heat tolerance, and herbicide tolerance, are all aimed at making agricultural production more economically efficient and environmentally sound. Arcadia’s nutrition products create healthier ingredients and whole foods.   Arcadia has granted more than 70 technology licenses worldwide to major seed and consumer product companies. The company was named one of MIT Technology Review's 50 Smartest Companies (2014) and has been recognized by AlwaysON as one of the GoingGreen Silicon Valley Global 200 (2011 and 2012).

ARCADIA BIOSCIENCES, INC.

Enhancing seed and crop traits via biotechnology

Crop Biotech

Companies that develop or use biological, physical and chemical agents and techniques to provide protection and improve the quality of a seed. This includes the sale of seed coating, or seed enhancement products as methods to treat seeds.

Companies that redesign large clusters of genes and gene parts rather than modifying or engineering a single gene for improving the traits of a plant.

Companies that utilize genetic engineering tools and technologies to use existing and naturally present gene variants in a plant and the natural process of breeding such as inbreeding, and linebreeding to develop better traits for plants.

Companies that use transgenesis processes like tissue culturing to develop transgenic plants or seeds by inserting new genes into them from other plants or in certain instances other organisms like bacteria or even animals.

Companies that offer techniques such as epigenetics, RNA interference (RNAi) to temporarily block a specific gene that would trigger unwanted effect such as a disease on a plant.

Companies that develop a platform to insert, edit, or delete the DNA of a plant itself using approaches such as CRISPR-Cas 9, TALENs, and Zinc Fingers. These approaches help develop plant genes or seeds with traits such as disease-resistant, enhanced-performance, or improve yield.

Arcadia Biosciences

Featured Industries

About EDGE

Contact Us

Resources

Area of Focus

Technology Research Made Effortless